Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03940586
What this trial is testing

Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (MK-8228-030)

Who this might be right for
Cytomegalovirus (CMV) Infection
Merck Sharp & Dohme LLC 65
Testing effectiveness (Phase 2)Looking for participantsNCT07072494
What this trial is testing

CD19 CAR-T Cell Infusion as Consolidation Therapy in Adolescent and Adult Patients With Acute B-ALL Ineligible for Allogeneic HSCT: A Clinical Study

Who this might be right for
Acute Lymphoblastic Leukemia
Zhujiang Hospital 30
Large-scale testing (Phase 3)Study completedNCT00775931
What this trial is testing

Allogeneic Transplantation For Severe Osteopetrosis

Who this might be right for
Severe Osteopetrosis
Masonic Cancer Center, University of Minnesota 7
Testing effectiveness (Phase 2)Study completedNCT00539695
What this trial is testing

Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD

Who this might be right for
Acute Lymphoblastic LeukemiaALLAcute Myelogenous Leukemia+7 more
Baylor College of Medicine 25
Testing effectiveness (Phase 2)Looking for participantsNCT07362095
What this trial is testing

Luspatercept for the Treatment of Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation(Allo-HSCT)

Who this might be right for
Acute Leukemia
Zhujiang Hospital 46
Large-scale testing (Phase 3)Not Yet RecruitingNCT07178457
What this trial is testing

Brentuximab Vedotin in CutAneous T-cell Lymphomas (CTCL): Post-allogeneic Hematopoietic Stem Cell Transplant Maintenance

Who this might be right for
Cutaneous T Cell Lymphoma (CTCL)Brentuximab Vedotin
Assistance Publique - Hôpitaux de Paris 84
Early research (Phase 1)Looking for participantsNCT06809712
What this trial is testing

Human Leukocyte Antigen (HLA) Mismatched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematologic Disease
He Huang 29
Not applicableStudy completedNCT03889028
What this trial is testing

Pre-engraftment Cytomegalovirus DNAemia

Who this might be right for
CMV DNAemia Pre-engraftment
Fundación para la Investigación del Hospital Clínico de Valencia 878
Not applicableLooking for participantsNCT03357172
What this trial is testing

Determination of Factors Involved in the Regulation of Immune Responses After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplantation
Central Hospital, Nancy, France 700
Testing effectiveness (Phase 2)Study completedNCT01660607
What this trial is testing

Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell

Who this might be right for
Myeloid Leukemia, ChronicAcute Myelogenous LeukemiaMyelodysplastic Syndromes (MDS)+6 more
Stanford University 68
Not applicableUnknownNCT04822532
What this trial is testing

Precision Dosing of Busulfan in Children Undergoing HSCT

Who this might be right for
Hematopoietic Stem Cell TransplantationAllogeneic Hematopoietic Stem Cell TransplantationAutologous Hematopoietic Stem Cell Transplantation
University Hospital, Geneva 260
Not applicableStudy completedNCT04798495
What this trial is testing

Feasibility of a Rehabilitation Programme Targeted Patients Treated With Non-myeloablative Stem Cell Transplantation

Who this might be right for
Stem Cell TransplantationRehabilitation
Aarhus University Hospital 30
Very early researchLooking for participantsNCT06398457
What this trial is testing

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

Who this might be right for
Hematologic MalignancyBone Marrow Transplant RejectionAcute Myeloid Leukemia (AML)+9 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Testing effectiveness (Phase 2)UnknownNCT01549665
What this trial is testing

Umbilical Cord Blood-derived Mesenchymal Stem Cells for the Treatment of Steroid-refractory Acute or Chronic Graft-versus-host-disease

Who this might be right for
Graft-Versus-Host DiseaseGVHDAllogeneic Hematopoietic Transplant+1 more
Samsung Medical Center 30
Not applicableUnknownNCT05200338
What this trial is testing

Preservation and Transfer of HBV Immunity After Allogeneic HSCT for SCD

Who this might be right for
Sickle Cell Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 30
Testing effectiveness (Phase 2)Study completedNCT01063647
What this trial is testing

Dose-range Finding Treosulfan-based Conditioning

Who this might be right for
Hematological Malignancies
medac GmbH 56
Not applicableUnknownNCT02643589
What this trial is testing

Dose Study of Antithymocyteglobulin in Haploidentical Allogeneic Stem Cell Transplantation

Who this might be right for
Hematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 200
Post-approval studies (Phase 4)UnknownNCT01135589
What this trial is testing

Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation

Who this might be right for
NeutropeniaHematopoietic Stem Cell TransplantationInvasive Fungal Disease
Asan Medical Center 145
Not applicableStudy completedNCT03401268
What this trial is testing

Subcutaneous Ig in Allogeneic Stem Cell Transplant Recipients

Who this might be right for
Hypogammaglobulinemia
University Health Network, Toronto 20
Testing effectiveness (Phase 2)Ended earlyNCT00429026
What this trial is testing

Conditioning Regimen in Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Renal Cell Cancer
M.D. Anderson Cancer Center 40
Next Page